Core Viewpoint - The company has received approval for a new veterinary drug, which is expected to contribute to business growth [1] Group 1: Product Development - The product "Fluconazole Lotion" has been approved as a Class IV new veterinary drug [1] - The product is specifically designed for the treatment of canine dermatophytosis [1] - The development of this product involved collaboration with Nanjing Jindun Animal Pharmaceutical and other entities [1] Group 2: Financial Investment - The total research and development investment for the new veterinary drug amounted to 1.6443 million yuan [1] - The approval of the new veterinary drug is anticipated to create a new performance growth point for the company [1]